Review



ccl3‐fitc; clone‐rea257  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Miltenyi Biotec ccl3‐fitc; clone‐rea257
    Ccl3‐Fitc; Clone‐Rea257, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rea257/ccl3+rea257/pmc10152717-124-52-53
    Average 90 stars, based on 1 article reviews
    ccl3‐fitc; clone‐rea257 - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Chromatin Immunoprecipitation:

    Article Title: Metabolic plasticity of HIV-specific CD8 + T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection.
    Article Snippet: Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology Animals and other organisms Human research participants Clinical data Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used All antibodies used were obtained from commercial sources: Target, Fluorophore, Company, Clone, cat number, dilution 1/ Viral Suppression Assay CD4, FITC, eBioscience, RPA-T4, 11-0049-42, 75 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 25 CD27, PE, BD, M-T271, 560985, 15 CD45RA, BV421, BD, HI100, 562885, 30 Single cell sort CD3, AF700, BD, UCHT1, 561027, 75 3 nature research | reporting sum m ary O ctober 2018 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 CD45RA, BV421, BD, HI100, 562885, 30 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 25 CD27, PE, BD, M-T271, 560985, 15 Metabolite uptake CD3, AF700, BD, UCHT1, 561027, 75 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 CD45RA, BV421, BD, HI100, 562885, 30 CD27, PE, BD, M-T271, 560985, 15 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 30 Phenotyping HIF1a, PE, Biolegend, 546-16, 359703, 20 pAKT, AF488, Cell Signal, D9E, 4071S, 50 Granzyme B, PE-CF594, BD, GB11, 562462, 20 CCL3, APC-Vio770, Miltneyii, REA257, 130-103-632, 15 CD178/FASL, PE-Vio770, Miltenyi, NOK-1, 130-104-270, 20 CD45RA, BV650, BD, HI100, 563963, 30 CD197/CCR7, BV605, BD, 3D12, 563711, 15 CD8, BUV496, BD, RPA-T8, 564805, 50 CD3, BUV395, BD, UCHT1, 563548, 50 CD27, PERCP-Cy55, BD, M-T271, 560612, 30 pS6, Pacific Blue, Cell Signal, D57.2.2E, 8520S, 50 Intracellular Cytokine Assay Human IFNg, PE-Cy7, BD, B27, 557643, 40 IL-2, FITC, BD, 5344.111, 340448, 10 TNFa, PE-CF594, BD, Mab11, 562784, 20 CD107α, V450, BD, H4A3, 561345, 40 CD3, AF700, BD, UCHT1, 561027, 75 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 Granzyme B, PE, BD, GB11, 561142, 40 CD4, APC, BD, RPA-T4, 555349, 75 Intracellular Cytokine Assay Macaque CD3, AF700, BD, SP34-2, 557917, 30 CD8, APC-Cy7, BD, RPA-T8, 557760, 70 CD107a, V450, BD, H4A3, 561345, 40 IFNg PE-Cy7, BD, B27, 557643, 35 IL-2, PE, BD, MQ1-17H12, 559334, 12 TNFa, PE-CF594, BD, Mab11, 562784, 25 Perforin, FITC, Mabtech, Pf-344, 3465-7, 25 Validation All antibodies used for the analyses of human cells have been validated by the provider.

    Flow Cytometry:

    Article Title: Metabolic plasticity of HIV-specific CD8 + T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection.
    Article Snippet: Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology Animals and other organisms Human research participants Clinical data Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used All antibodies used were obtained from commercial sources: Target, Fluorophore, Company, Clone, cat number, dilution 1/ Viral Suppression Assay CD4, FITC, eBioscience, RPA-T4, 11-0049-42, 75 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 25 CD27, PE, BD, M-T271, 560985, 15 CD45RA, BV421, BD, HI100, 562885, 30 Single cell sort CD3, AF700, BD, UCHT1, 561027, 75 3 nature research | reporting sum m ary O ctober 2018 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 CD45RA, BV421, BD, HI100, 562885, 30 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 25 CD27, PE, BD, M-T271, 560985, 15 Metabolite uptake CD3, AF700, BD, UCHT1, 561027, 75 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 CD45RA, BV421, BD, HI100, 562885, 30 CD27, PE, BD, M-T271, 560985, 15 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 30 Phenotyping HIF1a, PE, Biolegend, 546-16, 359703, 20 pAKT, AF488, Cell Signal, D9E, 4071S, 50 Granzyme B, PE-CF594, BD, GB11, 562462, 20 CCL3, APC-Vio770, Miltneyii, REA257, 130-103-632, 15 CD178/FASL, PE-Vio770, Miltenyi, NOK-1, 130-104-270, 20 CD45RA, BV650, BD, HI100, 563963, 30 CD197/CCR7, BV605, BD, 3D12, 563711, 15 CD8, BUV496, BD, RPA-T8, 564805, 50 CD3, BUV395, BD, UCHT1, 563548, 50 CD27, PERCP-Cy55, BD, M-T271, 560612, 30 pS6, Pacific Blue, Cell Signal, D57.2.2E, 8520S, 50 Intracellular Cytokine Assay Human IFNg, PE-Cy7, BD, B27, 557643, 40 IL-2, FITC, BD, 5344.111, 340448, 10 TNFa, PE-CF594, BD, Mab11, 562784, 20 CD107α, V450, BD, H4A3, 561345, 40 CD3, AF700, BD, UCHT1, 561027, 75 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 Granzyme B, PE, BD, GB11, 561142, 40 CD4, APC, BD, RPA-T4, 555349, 75 Intracellular Cytokine Assay Macaque CD3, AF700, BD, SP34-2, 557917, 30 CD8, APC-Cy7, BD, RPA-T8, 557760, 70 CD107a, V450, BD, H4A3, 561345, 40 IFNg PE-Cy7, BD, B27, 557643, 35 IL-2, PE, BD, MQ1-17H12, 559334, 12 TNFa, PE-CF594, BD, Mab11, 562784, 25 Perforin, FITC, Mabtech, Pf-344, 3465-7, 25 Validation All antibodies used for the analyses of human cells have been validated by the provider.

    Magnetic Resonance Imaging:

    Article Title: Metabolic plasticity of HIV-specific CD8 + T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection.
    Article Snippet: Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology Animals and other organisms Human research participants Clinical data Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used All antibodies used were obtained from commercial sources: Target, Fluorophore, Company, Clone, cat number, dilution 1/ Viral Suppression Assay CD4, FITC, eBioscience, RPA-T4, 11-0049-42, 75 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 25 CD27, PE, BD, M-T271, 560985, 15 CD45RA, BV421, BD, HI100, 562885, 30 Single cell sort CD3, AF700, BD, UCHT1, 561027, 75 3 nature research | reporting sum m ary O ctober 2018 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 CD45RA, BV421, BD, HI100, 562885, 30 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 25 CD27, PE, BD, M-T271, 560985, 15 Metabolite uptake CD3, AF700, BD, UCHT1, 561027, 75 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 CD45RA, BV421, BD, HI100, 562885, 30 CD27, PE, BD, M-T271, 560985, 15 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 30 Phenotyping HIF1a, PE, Biolegend, 546-16, 359703, 20 pAKT, AF488, Cell Signal, D9E, 4071S, 50 Granzyme B, PE-CF594, BD, GB11, 562462, 20 CCL3, APC-Vio770, Miltneyii, REA257, 130-103-632, 15 CD178/FASL, PE-Vio770, Miltenyi, NOK-1, 130-104-270, 20 CD45RA, BV650, BD, HI100, 563963, 30 CD197/CCR7, BV605, BD, 3D12, 563711, 15 CD8, BUV496, BD, RPA-T8, 564805, 50 CD3, BUV395, BD, UCHT1, 563548, 50 CD27, PERCP-Cy55, BD, M-T271, 560612, 30 pS6, Pacific Blue, Cell Signal, D57.2.2E, 8520S, 50 Intracellular Cytokine Assay Human IFNg, PE-Cy7, BD, B27, 557643, 40 IL-2, FITC, BD, 5344.111, 340448, 10 TNFa, PE-CF594, BD, Mab11, 562784, 20 CD107α, V450, BD, H4A3, 561345, 40 CD3, AF700, BD, UCHT1, 561027, 75 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 Granzyme B, PE, BD, GB11, 561142, 40 CD4, APC, BD, RPA-T4, 555349, 75 Intracellular Cytokine Assay Macaque CD3, AF700, BD, SP34-2, 557917, 30 CD8, APC-Cy7, BD, RPA-T8, 557760, 70 CD107a, V450, BD, H4A3, 561345, 40 IFNg PE-Cy7, BD, B27, 557643, 35 IL-2, PE, BD, MQ1-17H12, 559334, 12 TNFa, PE-CF594, BD, Mab11, 562784, 25 Perforin, FITC, Mabtech, Pf-344, 3465-7, 25 Validation All antibodies used for the analyses of human cells have been validated by the provider.

    Suppression Assay:

    Article Title: Metabolic plasticity of HIV-specific CD8 + T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection.
    Article Snippet: Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology Animals and other organisms Human research participants Clinical data Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used All antibodies used were obtained from commercial sources: Target, Fluorophore, Company, Clone, cat number, dilution 1/ Viral Suppression Assay CD4, FITC, eBioscience, RPA-T4, 11-0049-42, 75 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 25 CD27, PE, BD, M-T271, 560985, 15 CD45RA, BV421, BD, HI100, 562885, 30 Single cell sort CD3, AF700, BD, UCHT1, 561027, 75 3 nature research | reporting sum m ary O ctober 2018 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 CD45RA, BV421, BD, HI100, 562885, 30 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 25 CD27, PE, BD, M-T271, 560985, 15 Metabolite uptake CD3, AF700, BD, UCHT1, 561027, 75 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 CD45RA, BV421, BD, HI100, 562885, 30 CD27, PE, BD, M-T271, 560985, 15 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 30 Phenotyping HIF1a, PE, Biolegend, 546-16, 359703, 20 pAKT, AF488, Cell Signal, D9E, 4071S, 50 Granzyme B, PE-CF594, BD, GB11, 562462, 20 CCL3, APC-Vio770, Miltneyii, REA257, 130-103-632, 15 CD178/FASL, PE-Vio770, Miltenyi, NOK-1, 130-104-270, 20 CD45RA, BV650, BD, HI100, 563963, 30 CD197/CCR7, BV605, BD, 3D12, 563711, 15 CD8, BUV496, BD, RPA-T8, 564805, 50 CD3, BUV395, BD, UCHT1, 563548, 50 CD27, PERCP-Cy55, BD, M-T271, 560612, 30 pS6, Pacific Blue, Cell Signal, D57.2.2E, 8520S, 50 Intracellular Cytokine Assay Human IFNg, PE-Cy7, BD, B27, 557643, 40 IL-2, FITC, BD, 5344.111, 340448, 10 TNFa, PE-CF594, BD, Mab11, 562784, 20 CD107α, V450, BD, H4A3, 561345, 40 CD3, AF700, BD, UCHT1, 561027, 75 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 Granzyme B, PE, BD, GB11, 561142, 40 CD4, APC, BD, RPA-T4, 555349, 75 Intracellular Cytokine Assay Macaque CD3, AF700, BD, SP34-2, 557917, 30 CD8, APC-Cy7, BD, RPA-T8, 557760, 70 CD107a, V450, BD, H4A3, 561345, 40 IFNg PE-Cy7, BD, B27, 557643, 35 IL-2, PE, BD, MQ1-17H12, 559334, 12 TNFa, PE-CF594, BD, Mab11, 562784, 25 Perforin, FITC, Mabtech, Pf-344, 3465-7, 25 Validation All antibodies used for the analyses of human cells have been validated by the provider.

    Recombinase Polymerase Amplification:

    Article Title: Metabolic plasticity of HIV-specific CD8 + T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection.
    Article Snippet: Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology Animals and other organisms Human research participants Clinical data Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used All antibodies used were obtained from commercial sources: Target, Fluorophore, Company, Clone, cat number, dilution 1/ Viral Suppression Assay CD4, FITC, eBioscience, RPA-T4, 11-0049-42, 75 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 25 CD27, PE, BD, M-T271, 560985, 15 CD45RA, BV421, BD, HI100, 562885, 30 Single cell sort CD3, AF700, BD, UCHT1, 561027, 75 3 nature research | reporting sum m ary O ctober 2018 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 CD45RA, BV421, BD, HI100, 562885, 30 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 25 CD27, PE, BD, M-T271, 560985, 15 Metabolite uptake CD3, AF700, BD, UCHT1, 561027, 75 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 CD45RA, BV421, BD, HI100, 562885, 30 CD27, PE, BD, M-T271, 560985, 15 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 30 Phenotyping HIF1a, PE, Biolegend, 546-16, 359703, 20 pAKT, AF488, Cell Signal, D9E, 4071S, 50 Granzyme B, PE-CF594, BD, GB11, 562462, 20 CCL3, APC-Vio770, Miltneyii, REA257, 130-103-632, 15 CD178/FASL, PE-Vio770, Miltenyi, NOK-1, 130-104-270, 20 CD45RA, BV650, BD, HI100, 563963, 30 CD197/CCR7, BV605, BD, 3D12, 563711, 15 CD8, BUV496, BD, RPA-T8, 564805, 50 CD3, BUV395, BD, UCHT1, 563548, 50 CD27, PERCP-Cy55, BD, M-T271, 560612, 30 pS6, Pacific Blue, Cell Signal, D57.2.2E, 8520S, 50 Intracellular Cytokine Assay Human IFNg, PE-Cy7, BD, B27, 557643, 40 IL-2, FITC, BD, 5344.111, 340448, 10 TNFa, PE-CF594, BD, Mab11, 562784, 20 CD107α, V450, BD, H4A3, 561345, 40 CD3, AF700, BD, UCHT1, 561027, 75 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 Granzyme B, PE, BD, GB11, 561142, 40 CD4, APC, BD, RPA-T4, 555349, 75 Intracellular Cytokine Assay Macaque CD3, AF700, BD, SP34-2, 557917, 30 CD8, APC-Cy7, BD, RPA-T8, 557760, 70 CD107a, V450, BD, H4A3, 561345, 40 IFNg PE-Cy7, BD, B27, 557643, 35 IL-2, PE, BD, MQ1-17H12, 559334, 12 TNFa, PE-CF594, BD, Mab11, 562784, 25 Perforin, FITC, Mabtech, Pf-344, 3465-7, 25 Validation All antibodies used for the analyses of human cells have been validated by the provider.

    Cytokine Assay:

    Article Title: Metabolic plasticity of HIV-specific CD8 + T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection.
    Article Snippet: Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology Animals and other organisms Human research participants Clinical data Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used All antibodies used were obtained from commercial sources: Target, Fluorophore, Company, Clone, cat number, dilution 1/ Viral Suppression Assay CD4, FITC, eBioscience, RPA-T4, 11-0049-42, 75 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 25 CD27, PE, BD, M-T271, 560985, 15 CD45RA, BV421, BD, HI100, 562885, 30 Single cell sort CD3, AF700, BD, UCHT1, 561027, 75 3 nature research | reporting sum m ary O ctober 2018 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 CD45RA, BV421, BD, HI100, 562885, 30 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 25 CD27, PE, BD, M-T271, 560985, 15 Metabolite uptake CD3, AF700, BD, UCHT1, 561027, 75 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 CD45RA, BV421, BD, HI100, 562885, 30 CD27, PE, BD, M-T271, 560985, 15 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 30 Phenotyping HIF1a, PE, Biolegend, 546-16, 359703, 20 pAKT, AF488, Cell Signal, D9E, 4071S, 50 Granzyme B, PE-CF594, BD, GB11, 562462, 20 CCL3, APC-Vio770, Miltneyii, REA257, 130-103-632, 15 CD178/FASL, PE-Vio770, Miltenyi, NOK-1, 130-104-270, 20 CD45RA, BV650, BD, HI100, 563963, 30 CD197/CCR7, BV605, BD, 3D12, 563711, 15 CD8, BUV496, BD, RPA-T8, 564805, 50 CD3, BUV395, BD, UCHT1, 563548, 50 CD27, PERCP-Cy55, BD, M-T271, 560612, 30 pS6, Pacific Blue, Cell Signal, D57.2.2E, 8520S, 50 Intracellular Cytokine Assay Human IFNg, PE-Cy7, BD, B27, 557643, 40 IL-2, FITC, BD, 5344.111, 340448, 10 TNFa, PE-CF594, BD, Mab11, 562784, 20 CD107α, V450, BD, H4A3, 561345, 40 CD3, AF700, BD, UCHT1, 561027, 75 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 Granzyme B, PE, BD, GB11, 561142, 40 CD4, APC, BD, RPA-T4, 555349, 75 Intracellular Cytokine Assay Macaque CD3, AF700, BD, SP34-2, 557917, 30 CD8, APC-Cy7, BD, RPA-T8, 557760, 70 CD107a, V450, BD, H4A3, 561345, 40 IFNg PE-Cy7, BD, B27, 557643, 35 IL-2, PE, BD, MQ1-17H12, 559334, 12 TNFa, PE-CF594, BD, Mab11, 562784, 25 Perforin, FITC, Mabtech, Pf-344, 3465-7, 25 Validation All antibodies used for the analyses of human cells have been validated by the provider.

    Biomarker Discovery:

    Article Title: Metabolic plasticity of HIV-specific CD8 + T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection.
    Article Snippet: Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology Animals and other organisms Human research participants Clinical data Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used All antibodies used were obtained from commercial sources: Target, Fluorophore, Company, Clone, cat number, dilution 1/ Viral Suppression Assay CD4, FITC, eBioscience, RPA-T4, 11-0049-42, 75 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 25 CD27, PE, BD, M-T271, 560985, 15 CD45RA, BV421, BD, HI100, 562885, 30 Single cell sort CD3, AF700, BD, UCHT1, 561027, 75 3 nature research | reporting sum m ary O ctober 2018 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 CD45RA, BV421, BD, HI100, 562885, 30 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 25 CD27, PE, BD, M-T271, 560985, 15 Metabolite uptake CD3, AF700, BD, UCHT1, 561027, 75 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 CD45RA, BV421, BD, HI100, 562885, 30 CD27, PE, BD, M-T271, 560985, 15 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 30 Phenotyping HIF1a, PE, Biolegend, 546-16, 359703, 20 pAKT, AF488, Cell Signal, D9E, 4071S, 50 Granzyme B, PE-CF594, BD, GB11, 562462, 20 CCL3, APC-Vio770, Miltneyii, REA257, 130-103-632, 15 CD178/FASL, PE-Vio770, Miltenyi, NOK-1, 130-104-270, 20 CD45RA, BV650, BD, HI100, 563963, 30 CD197/CCR7, BV605, BD, 3D12, 563711, 15 CD8, BUV496, BD, RPA-T8, 564805, 50 CD3, BUV395, BD, UCHT1, 563548, 50 CD27, PERCP-Cy55, BD, M-T271, 560612, 30 pS6, Pacific Blue, Cell Signal, D57.2.2E, 8520S, 50 Intracellular Cytokine Assay Human IFNg, PE-Cy7, BD, B27, 557643, 40 IL-2, FITC, BD, 5344.111, 340448, 10 TNFa, PE-CF594, BD, Mab11, 562784, 20 CD107α, V450, BD, H4A3, 561345, 40 CD3, AF700, BD, UCHT1, 561027, 75 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 Granzyme B, PE, BD, GB11, 561142, 40 CD4, APC, BD, RPA-T4, 555349, 75 Intracellular Cytokine Assay Macaque CD3, AF700, BD, SP34-2, 557917, 30 CD8, APC-Cy7, BD, RPA-T8, 557760, 70 CD107a, V450, BD, H4A3, 561345, 40 IFNg PE-Cy7, BD, B27, 557643, 35 IL-2, PE, BD, MQ1-17H12, 559334, 12 TNFa, PE-CF594, BD, Mab11, 562784, 25 Perforin, FITC, Mabtech, Pf-344, 3465-7, 25 Validation All antibodies used for the analyses of human cells have been validated by the provider.

    Staining:

    Article Title: Metabolic plasticity of HIV-specific CD8 + T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection.
    Article Snippet: Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology Animals and other organisms Human research participants Clinical data Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used All antibodies used were obtained from commercial sources: Target, Fluorophore, Company, Clone, cat number, dilution 1/ Viral Suppression Assay CD4, FITC, eBioscience, RPA-T4, 11-0049-42, 75 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 25 CD27, PE, BD, M-T271, 560985, 15 CD45RA, BV421, BD, HI100, 562885, 30 Single cell sort CD3, AF700, BD, UCHT1, 561027, 75 3 nature research | reporting sum m ary O ctober 2018 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 CD45RA, BV421, BD, HI100, 562885, 30 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 25 CD27, PE, BD, M-T271, 560985, 15 Metabolite uptake CD3, AF700, BD, UCHT1, 561027, 75 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 CD45RA, BV421, BD, HI100, 562885, 30 CD27, PE, BD, M-T271, 560985, 15 CD197/CCR7, PE-Cy7, Biolegend, G043H7, 353226, 30 Phenotyping HIF1a, PE, Biolegend, 546-16, 359703, 20 pAKT, AF488, Cell Signal, D9E, 4071S, 50 Granzyme B, PE-CF594, BD, GB11, 562462, 20 CCL3, APC-Vio770, Miltneyii, REA257, 130-103-632, 15 CD178/FASL, PE-Vio770, Miltenyi, NOK-1, 130-104-270, 20 CD45RA, BV650, BD, HI100, 563963, 30 CD197/CCR7, BV605, BD, 3D12, 563711, 15 CD8, BUV496, BD, RPA-T8, 564805, 50 CD3, BUV395, BD, UCHT1, 563548, 50 CD27, PERCP-Cy55, BD, M-T271, 560612, 30 pS6, Pacific Blue, Cell Signal, D57.2.2E, 8520S, 50 Intracellular Cytokine Assay Human IFNg, PE-Cy7, BD, B27, 557643, 40 IL-2, FITC, BD, 5344.111, 340448, 10 TNFa, PE-CF594, BD, Mab11, 562784, 20 CD107α, V450, BD, H4A3, 561345, 40 CD3, AF700, BD, UCHT1, 561027, 75 CD8, APC-Cy7, BD, RPA-T8, 557760, 75 Granzyme B, PE, BD, GB11, 561142, 40 CD4, APC, BD, RPA-T4, 555349, 75 Intracellular Cytokine Assay Macaque CD3, AF700, BD, SP34-2, 557917, 30 CD8, APC-Cy7, BD, RPA-T8, 557760, 70 CD107a, V450, BD, H4A3, 561345, 40 IFNg PE-Cy7, BD, B27, 557643, 35 IL-2, PE, BD, MQ1-17H12, 559334, 12 TNFa, PE-CF594, BD, Mab11, 562784, 25 Perforin, FITC, Mabtech, Pf-344, 3465-7, 25 Validation All antibodies used for the analyses of human cells have been validated by the provider.



    Similar Products

    ccl3‐fitc; clone‐rea257  (Miltenyi Biotec)
    90
    Miltenyi Biotec ccl3‐fitc; clone‐rea257
    Ccl3‐Fitc; Clone‐Rea257, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rea257/ccl3+rea257/pmc10152717-124-52-53
    Average 90 stars, based on 1 article reviews
    ccl3‐fitc; clone‐rea257 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    rea257  (Miltenyi Biotec)
    91
    Miltenyi Biotec rea257
    Rea257, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rea257/CCL3+(MIP-1%CE%B1)+Antibody%2C+anti-human%2C+REAfinity/pm32694646-486-180-185
    Average 91 stars, based on 1 article reviews
    rea257 - by Bioz Stars, 2026-09
    91/100 stars
    		  Buy from Supplier
    ccl3 (mip-1α) antibody, anti-human, reafinity  (Miltenyi Biotec)
    91
    Miltenyi Biotec ccl3 (mip-1α) antibody, anti-human, reafinity
    Ccl3 (Mip 1α) Antibody, Anti Human, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rea257/CCL3+(MIP-1%CE%B1)+Antibody%2C+anti-human%2C+REAfinity/custom%40130-131-213%4031242243
    Average 91 stars, based on 1 article reviews
    ccl3 (mip-1α) antibody, anti-human, reafinity - by Bioz Stars, 2026-09
    91/100 stars
    		  Buy from Supplier

    Image Search Results